We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
(-8%)
Cap. Flow
-$1.7B
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$219M |
| 2 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
+$185M |
| 3 |
Ross Stores
ROST
|
+$144M |
| 4 |
Progressive
PGR
|
+$134M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.49B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$762M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$476M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$348M |
| 5 |
Archer Daniels Midland
ADM
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.9% |
| 2 | Industrials | 13.89% |
| 3 | Financials | 12.91% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Healthcare | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Axalta
AXTA
$7.97B
| $749K | ﹤0.01% |
29,534
-1,691
| -5% | -$47.3K |
|
1927
PBF Energy
PBF
$8.19B
| $748K | ﹤0.01% |
25,725
+13,830
| +116% | +$261K |
|
1928
GATX Corp
GATX
$6.27B
| $746K | ﹤0.01% |
7,214
+3,391
| +89% | +$371K |
|
1929
Sabre
SABR
$815M
| $746K | ﹤0.01% |
71,292
+30,830
| +76% | +$302K |
|
1930
John B. Sanfilippo & Son
JBSS
$979M
| $745K | ﹤0.01% |
9,601
+2,784
| +41% | +$231K |
|
|
SHOE
1931
Shoe Station Group
SHOE
$423M
| $745K | ﹤0.01% |
24,864
+9,191
| +59% | +$300K |
|
|
ETRN
1932
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $745K | ﹤0.01% |
93,930
+43,476
| +86% | +$358K |
|
1933
Digital Turbine
APPS
$1.63B
| $744K | ﹤0.01% |
23,500
+4,405
| +23% | +$199K |
|
1934
Antero Midstream
AM
$10.5B
| $743K | ﹤0.01% |
72,387
+31,405
| +77% | +$319K |
|
1935
SPX Corp
SPXC
$11B
| $741K | ﹤0.01% |
17,695
+6,358
| +56% | +$329K |
|
1936
Heartland Express
HTLD
$918M
| $738K | ﹤0.01% |
53,398
+11,803
| +28% | +$176K |
|
1937
Rapid7
RPD
$908M
| $738K | ﹤0.01% |
7,722
-1
| -0% | -$100 |
|
1938
Howard Hughes
HHH
$4.02B
| $735K | ﹤0.01% |
7,690
-219
| -3% | -$20.2K |
|
1939
Axos Financial
AX
$5.69B
| $734K | ﹤0.01% |
19,373
+5,360
| +38% | +$283K |
|
|
CTHR
1940
DELISTED
Charles & Colvard Ltd
CTHR
| $734K | ﹤0.01% |
46,742
+11,707
| +33% | +$240K |
|
1941
US Physical Therapy
USPH
$1.22B
| $731K | ﹤0.01% |
7,040
+2,266
| +47% | +$216K |
|
|
JBGS
1942
JBG SMITH
JBGS
$667M
| $729K | ﹤0.01% |
27,674
+10,501
| +61% | +$296K |
|
1943
O-I Glass
OI
$1.1B
| $728K | ﹤0.01% |
53,993
+20,176
| +60% | +$263K |
|
1944
Viavi Solutions
VIAV
$9.51B
| $727K | ﹤0.01% |
50,693
+20,612
| +69% | +$340K |
|
1945
Mercury Systems
MRCY
$6.45B
| $726K | ﹤0.01% |
12,884
-621
| -5% | -$36.9K |
|
1946
Seacoast Banking Corp of Florida
SBCF
$3.41B
| $726K | ﹤0.01% |
22,324
+6,459
| +41% | +$235K |
|
1947
Forrester Research
FORR
$225M
| $724K | ﹤0.01% |
12,971
+1,680
| +15% | +$90.6K |
|
1948
Maravai LifeSciences
MRVI
$878M
| $723K | ﹤0.01% |
23,515
+1,904
| +9% | +$63.8K |
|
1949
Yelp
YELP
$1.31B
| $723K | ﹤0.01% |
22,221
+8,446
| +61% | +$290K |
|
1950
CVB Financial
CVBF
$4.01B
| $721K | ﹤0.01% |
31,306
-357,953
| -92% | -$8.28M |
|
Similar funds
VGA
Victory Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.
- Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
- Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
- Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
- Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
- Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
- Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
- Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.
Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.